p53 anti-tumor research in bel-7402 by using human-derived vector

Progress in Biochemistry and Biophysics

Volumn 34, Issue 5, 2007, Pages 465-470

  Xue, Zhi Gang ^a   Li, Jian ^a   Yin, Biao ^a   Zhang, Ya Kun ^a   Liu, Xiang Hao ^a   Pan, Qian ^a   Long, Zhi Gao ^a   Dai, He Ping ^a   Xia, Kun ^a   Wu, Ling Qian ^a   Liang, De Sheng ^a   Xia, Jia Hui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Human telomeras reverse transcriptase (hTERT); Human derived vector; p53

Indexed keywords

EID: 34547747231     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Liu X H, Liu M J, She H, et al. Expression of reconstructive hFVIII in the hrDNA by using hrDNA targeting vector. Chin Sci Bull, 2005, 50 (19): 2187-2192
2. Wirth T, Zender L, Schulte B. A Telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer. Cancer Research, 2003, 63: 3181
3. Jacob D, Bahra M, Schumacher G, et al. Gene therapy in colon cancer cells with a fiber-modified adenovector expressing the TRAIL gene driven by the hTERT promoter. Anticancer Research, 2004, 24 (5A): 3075-3079
4. Wang L, Xue Z G, Li Z, et al. Investigation of hrDNA targeting vector-mediated tumor-specific suicide gene therapy for hepatocellular carcinoma. Chin Sci Bull, 2006, 51 (19): 2342 -2350
5. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science, 1991, 253: 49-53
6. Donehower L A, Michele H, Betty L, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 1992, 356 (6366): 215-221
7. Malkin D, Li F P, Strong L C, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.Science, 1990, 250 (4985): 1233-1238
8. Srivastava S, Zou Z Q, Pirollo K, et al. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature, 1990, 348 (6303): 747-749
9. Miranda T, Kalita A, Labrecque S, et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Molecular and Cellular Biology, 1999, 19 (2): 1092-1100
10. Taro K, Satoru K, Katsuyuki H, et al. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clinical Cancer Research, 2000, 6 (4): 1239-1247
11. Xu D W, Wang Q, Gruber A, et al. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene, 2000, 19 (45): 5123-5133
12. Stampfer M R, Garbe J, Mizumoto K, et al. Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines. Oncogene, 2003, 22 (34): 5238-5251
13. Boldrini L, Faviana P, Gisfredi S, et al. Regulation of telomerase and its hTERT messenger in colorectal cancer. Oncology Reports, 2004, 11 (2): 395-400
14. Rahman R, Latonen L, Wiman K G. hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene, 2005, 24 (8): 1320-1327
15. Yan B Z, Wang J, Zhang B, et al. Inhibitory effect of p53 gene on telomerase activity and proliferative activity in salivary adenoid cystic carcinoma cells. Chin J Stomatol, 2006, 41 (1): 45-48
16. Tang F, Gu D H, Wang H, et al. Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53. Chin J Oncol, 2006, 28 (3): 192-195